Judith & Stewart Colton Center for Autoimmunity | NYU Langone Health

Skip to Main Content
Department of Medicine Research Judith & Stewart Colton Center for Autoimmunity

Judith & Stewart Colton Center for Autoimmunity

At NYU Langone’s Judith and Stewart Colton Center for Autoimmunity, physicians and scientists collaborate on research to better understand the immunological basis of autoimmunity and develop new diagnostic tools and treatments for people with autoimmune diseases.

We integrate science and technology, and encourage a collaborative culture between researchers and clinicians of diverse expertise. Our aim is to foster transformative discoveries about the environmental triggers and immunological events that characterize autoimmune disease onset.

Our approach to translational research builds on a tradition of strong basic and clinical sciences, and well-characterized patient cohorts. Studies from the Judith and Stewart Colton Center for Autoimmunity have investigated a number of autoimmune diseases, including systemic lupus erythematosus, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Behcet’s syndrome, inflammatory bowel disease, multiple sclerosis, and myasthenia gravis.

Leadership

The Judith and Stewart Colton Center for Autoimmunity is overseen by director Timothy Niewold, MD, who is internationally recognized for his research in the field of autoimmunity and genetics. Dr. Niewold has published more than 150 papers in peer-reviewed journals. With funding from the National Institutes of Health (NIH), the Niewold Lab is examining the role of type I interferon in the development of lupus, as well as biomarkers of treatment response in patients with rheumatoid arthritis.

Internal Advisory Committee Members

Jef D. Boeke, PhD
Director, Institute for Systems Genetics
Professor, Department of Biochemistry and Molecular Pharmacology

Robert J. Schneider, PhD
Associate Dean, Therapeutics Alliances
Director, Translational Research, Perlmutter Cancer Center
The Albert B. Sabin Professor of Microbiology and Molecular Pathogenesis, Department of Microbiology
Professor, Department of Radiation Oncology

Jeffrey N. Weiser, MD
Chair, Department of Microbiology
The Jan T. Vilcek Professor of Molecular Pathogenesis, Department of Microbiology

Itai Yanai, PhD
Director, Institute for Computational Medicine
Professor, Department of Biochemistry and Molecular Pharmacology

External Advisory Committee Members

Joseph E. Craft, MD
Section Chief, Rheumatology
Program Director, Investigative Medicine
Yale School of Medicine

Bevra H. Hahn, MD
Vice Chair of Medicine and Chief, Division of Rheumatology
David Geffen School of Medicine at University of California, Los Angeles (UCLA)

Judith A. James, MD, PhD
Vice President of Clinical Affairs
Member and Program Chair, Arthritis and Clinical Immunology Research Program
Oklahoma Medical Research Foundation

Jarrat Jordan, PhD
Director, Lupus Biomarkers
Janssen, Inc.

Dan Kastner, MD, PhD
NIH Distinguished Investigator
Scientific Director
National Human Genome Research Institute

Curtis Keith, PhD
Chief Scientific Officer, Blavatnik Biomedical Accelerator
Harvard University

Isaac T. Kohlberg
Senior Associate Provost and Chief Technology Development Officer
Harvard University

Yehuda Shoenfeld, MD
Head of Zabludowicz Center for Autoimmune Diseases at Sheba Medical Center, Tel Hashomer
Tel Aviv University

Daniel J. Wallace, MD
Professor of Medicine, Cedars-Sinai Medical Center
Clinical Professor of Medicine, David Geffen School of Medicine at University of California, Los Angeles